Paper20143445
Killing tumor cells through their surface beta(2)-microglobulin or major histocompatibility complex class I molecules.
Yang J and 1 other. Cancer, 2010. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Killing tumor cells through their surface beta(2)-microglobulin or major histocompatibility complex class I molecules. Papers, record 20143445. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20143445
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Killing tumor cells through their surface beta(2)-microglobulin or major histocompatibility complex class I molecules.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| Apoptosis | |
| Cell Line, Tumor | |
| Drug Delivery Systems | |
| Hematologic Neoplasms | |
| Histocompatibility Antigens Class I | |
| Membrane Microdomains | |
| Mice | |
| Signal Transduction | |
| beta 2-Microglobulin |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA96569 | NCI NIH HHS | United States | R01CA096569 | PubMed and NIH | NIH RePORTER |
| R01 CA138402 | NCI NIH HHS | United States | R01CA138402 | PubMed and NIH | NIH RePORTER |
| R01 CA096569 | NCI NIH HHS | United States | R01CA096569 | PubMed and NIH | NIH RePORTER |
| R00 CA137158 | NCI NIH HHS | United States | K99CA137158 | PubMed and NIH | NIH RePORTER |
| R01 CA103978 | NCI NIH HHS | United States | R01CA103978 | PubMed and NIH | NIH RePORTER |
| K99 CA137158 | NCI NIH HHS | United States | K99CA137158 | PubMed and NIH | NIH RePORTER |
| K99/R00 CA137158 | NCI NIH HHS | United States | PubMed | PubMed | |
| R00CA137158 | NIH | NIH RePORTER |
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11426640 | The EGF receptor family as targets for cancer therapy. | Oncogene | 2000 | https://conductscience.org/library/papers/11426640 | PubMed |
| 2 | 6357266 | Serum beta2 microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging. | Br J Haematol | 1983 | https://conductscience.org/library/papers/6357266 | PubMed |
| 3 | 7913109 | Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules. | J Immunol | 1994 | https://conductscience.org/library/papers/7913109 | PubMed |
| 4 | 17189401 | Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/17189401 | PubMed |
| 5 | 10575274 | MHC class I cross-talk with CD2 and CD28 induces specific intracellular signalling and leads to growth retardation and apoptosis via a p56(lck)-dependent mechanism. | Exp Clin Immunogenet | 1999 | https://conductscience.org/library/papers/10575274 | PubMed |
| 6 | 12190923 | Human histocompatibility proteins. | Immunol Rev | 2002 | https://conductscience.org/library/papers/12190923 | PubMed |
| 7 | 2196997 | Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen. | Cell | 1990 | https://conductscience.org/library/papers/2196997 | PubMed |
| 8 | 10414913 | Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma. | Bone Marrow Transplant | 1999 | https://conductscience.org/library/papers/10414913 | PubMed |
| 9 | 7949178 | Interleukin-6 prevents dexamethasone-induced myeloma cell death. | Blood | 1994 | https://conductscience.org/library/papers/7949178 | PubMed |
| 10 | 9973532 | The cytoplasmic and the transmembrane domains are not sufficient for class I MHC signal transduction. | Cell Immunol | 1999 | https://conductscience.org/library/papers/9973532 | PubMed |
| 11 | 9700509 | The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28. | Immunol Rev | 1998 | https://conductscience.org/library/papers/9700509 | PubMed |
| 12 | 9345047 | Fas-independent apoptosis of activated T cells induced by antibodies to the HLA class I alpha1 domain. | Blood | 1997 | https://conductscience.org/library/papers/9345047 | PubMed |
| 13 | 15222125 | Non-immune functions of MHC class I glycoproteins in normal and malignant cells. | Folia Biol (Praha) | 2004 | https://conductscience.org/library/papers/15222125 | PubMed |
| 14 | 12482878 | Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12482878 | PubMed |
| 15 | 8296156 | Signal transduction via MHC class-I molecules in T cells. | Scand J Immunol | 1994 | https://conductscience.org/library/papers/8296156 | PubMed |
| 16 | 7529791 | MHC class I signaling in T cells leads to tyrosine kinase activity and PLC-gamma 1 phosphorylation. | J Immunol | 1995 | https://conductscience.org/library/papers/7529791 | PubMed |
| 17 | 9226173 | Antibodies to HLA class I alpha1 domain trigger apoptosis of CD40-activated human B lymphocytes. | Blood | 1997 | https://conductscience.org/library/papers/9226173 | PubMed |
| 18 | 3263428 | Possible association between IL-2 receptors and class I HLA molecules on T cells. | J Immunol | 1988 | https://conductscience.org/library/papers/3263428 | PubMed |
| 19 | 8246175 | Correlation between insulin receptor occupancy and tyrosine kinase activity at low insulin concentrations and effect of major histocompatibility complex class I-derived peptide. | J Pharmacol Exp Ther | 1993 | https://conductscience.org/library/papers/8246175 | PubMed |
| 20 | 91458 | Study of serum beta-2 microglobulin levels in breast cancer patients. | Clin Chim Acta | 1979 | https://conductscience.org/library/papers/91458 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40283167 | Disrupted Redox Regulation and Inflammatory Response in Pyoderma Gangrenosum. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40283167 | PubMed |
| 39128984 | β2-microglobulin induced apoptosis of tumor cells via the ERK signaling pathway by directly interacting with HFE in HER2-overexpressing breast cancer. | BMC Cancer | 2024 | https://conductscience.org/library/papers/39128984 | PubMed |
| 38074293 | Molecular and translational biology of the blood-based VeriStrat® proteomic test used in cancer immunotherapy treatment guidance. | J Mass Spectrom Adv Clin Lab | 2023 | https://conductscience.org/library/papers/38074293 | PubMed |
| 37500738 | β2-microglobulin and colorectal cancer among inpatients: a case-control study. | Sci Rep | 2023 | https://conductscience.org/library/papers/37500738 | PubMed |
| 35280986 | Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation. | Front Immunol | 2022 | https://conductscience.org/library/papers/35280986 | PubMed |
| 33384693 | Reverse Signaling by MHC-I Molecules in Immune and Non-Immune Cell Types. | Front Immunol | 2020 | https://conductscience.org/library/papers/33384693 | PubMed |
| 33235502 | Combined Diagnostic Significance of Preoperative Serum β2-Microglobulin and Routine Blood Test in Patients with High-grade Glioma and Solitary Brain Metastasis. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/33235502 | PubMed |
| 31900803 | Promotion on NLRC5 upregulating MHC-I expression by IFN-γ in MHC-I-deficient breast cancer cells. | Immunol Res | 2019 | https://conductscience.org/library/papers/31900803 | PubMed |
| 31583257 | MHC Class I Molecules Exacerbate Viral Infection by Disrupting Type I Interferon Signaling. | J Immunol Res | 2019 | https://conductscience.org/library/papers/31583257 | PubMed |
| 29867922 | SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes. | Front Immunol | 2018 | https://conductscience.org/library/papers/29867922 | PubMed |
| 26611618 | Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance. | Cancer Immunol Immunother | 2016 | https://conductscience.org/library/papers/26611618 | PubMed |
| 25311765 | ATP5b and β2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer. | J Mol Histol | 2015 | https://conductscience.org/library/papers/25311765 | PubMed |
| 23848204 | β2-Microglobulin-mediated signaling as a target for cancer therapy. | Anticancer Agents Med Chem | 2014 | https://conductscience.org/library/papers/23848204 | PubMed |
| 23671189 | Tumor necrosis factor α-induced hypoxia-inducible factor 1α-β-catenin axis regulates major histocompatibility complex class I gene activation through chromatin remodeling. | Mol Cell Biol | 2013 | https://conductscience.org/library/papers/23671189 | PubMed |
| 22430632 | Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors. | Leukemia | 2012 | https://conductscience.org/library/papers/22430632 | PubMed |
| 21829193 | Supernatants from lymphocytes stimulated with Bacillus Calmette-Guerin can modify the antigenicity of tumours and stimulate allogeneic T-cell responses. | Br J Cancer | 2011 | https://conductscience.org/library/papers/21829193 | PubMed |
Genes35
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20143445
GET https://conductscience.org/api/papers/v1/20143445/references?page=2